Related Experiment Video
Updated: Jun 5, 2026

Assessment of Child Anthropometry in a Large Epidemiologic Study
Published on: February 2, 2017
Otitis media and associations with overweight status in toddlers
H M Nelson1, K A Daly, C S Davey
1University of Minnesota, Department of Otolaryngology, MMC 396, 420 Delaware St. SE, Minneapolis, MN 55455, USA. nels1226@umn.edu
Insights
Recurrent otitis media (OM) treated with tympanostomy tubes is linked to a higher risk of childhood overweight. This study highlights a significant association between ear infections requiring tubes and increased weight-for-length in children.
Area of Science:
- Pediatrics
- Epidemiology
- Otolaryngology
Background:
- Otitis media (OM) is a common childhood illness with potential links to later overweight status.
- Childhood overweight is a growing epidemic, necessitating research into contributing factors.
- Previous studies suggest physiological mechanisms connecting OM history, food preferences, and overweight development.
Purpose of the Study:
- To investigate the association between recurrent otitis media (ROM) or tympanostomy tube treatment and overweight status in children.
- To explore potential risk factors for childhood overweight related to ear infection history.
Main Methods:
- Analysis of a prospective cohort of mothers and children (1991-1996).
- Categorical analysis of ROM and tympanostomy tube status using weight-for-length (WFL) data from well-child visits.
- Univariate and multivariate analyses utilizing chi-square and logistic regression.
Main Results:
- 11.4% of children exhibited a weight-for-length (WFL) at two years of age at or above the 95th percentile.
- Children with a history of tympanostomy tube treatment showed a significantly elevated risk (OR 3.32) of WFL ≥ 95th percentile, even after controlling for covariates.
- No significant association was found between WFL at two months and the number of OM episodes by two years.
Conclusions:
- Findings support the hypothesis that OM requiring tympanostomy tube treatment is associated with overweight status in children.
- The study reinforces prior research linking ear infections and subsequent weight issues.
- Tympanostomy tube treatment for OM may be a marker for increased risk of childhood overweight.
Introduction:
Otitis media (OM) is a significant disease that affects nearly all children early in life. Recently, childhood overweight has become an epidemic. Past research has demonstrated that a history of OM is related to food preferences and overweight through proposed physiological mechanisms. The purpose of this study was to explore the relationship between recurrent OM (ROM)/tympanostomy tube treatment and overweight status.
Methods:
Data were analyzed from a prospective cohort of mothers and children recruited from 1991-1996 from a local health maintenance organization. ROM and tympanostomy tube status were obtained through a combination of physical exam and medical record abstraction. ROM and tympanostomy tube status were analyzed as categorical variables with weight-for-length (WFL) data from well child checks. Chi-square and logistic regression for univariate and multivariate analyses were performed.
Results:
11.4% of children had a WFL measure at two years of age ≥ 95 th percentile. Those children with a history of tympanostomy tube treatment had a significantly increased risk of having a WFL ≥ 95 th percentile after controlling for birth weight, maternal prenatal smoking, maternal education, and family income (OR 3.32, 95% CI 1.43-7.72). The alternative hypothesis that children with larger WFL at two month of age would have a greater number of OM episodes by two years of age was not significant.
Conclusion:
The findings of this study are consistent with the hypothesis and prior research that OM treated with tympanostomy tubes is associated with overweight status.
Related Concept Videos
Obesity
Tonsillitis I: Introduction
Etiology
Three primary contributing factors have been identified.
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Development of the Oral Microbiota
Type II Diabetes I: Introduction
Drug Dosing: Obese Patients
